摘要
131I是治疗甲状腺功能亢进症(甲亢)的主要药物之一,治疗前应用硫氧嘧啶类药物如丙硫氧嘧啶可能会降低131I治疗甲亢的治愈率,咪唑类药物如甲巯咪唑则不会影响其疗效。131I治疗甲亢后应用丙硫氧嘧啶或甲巯咪唑对131I疗效的影响尚有争议之处。抗甲状腺药物影响131I疗效的机理可能在于改变了131I的有效半衰期和(或)甲状腺对131I的摄取率。
^131Ⅰ plays an important role in the treatment of hyperthyroidism. Propylthiouracil, which is used before ^131Ⅰ, can reduce the efficacy of ^131Ⅰ. However, methimazole does not. There exits contrary ideas about whether propylthiouracil and methimazole used after ^131Ⅰ might influence its efficacy. Antithyroid drugs may influence the efficacy of ^131Ⅰ, the possible mechanism might be that antithyroid drugs change the effective half-time and (or) uptake of ^131Ⅰ.
出处
《国际内分泌代谢杂志》
2006年第5期342-343,350,共3页
International Journal of Endocrinology and Metabolism